{
    "case_number": "CAC-UDRP-107436",
    "time_of_filling": "2025-03-26 09:33:21",
    "domain_names": [
        "novartismanagement.com"
    ],
    "case_administrator": "Olga Dvořáková (Case admin)",
    "complainant": [
        "Novartis AG"
    ],
    "complainant_representative": "Abion GmbH",
    "respondent": [
        "Louanna Robelia"
    ],
    "respondent_representative": null,
    "factual_background": "<p style=\"font-weight: 400;\"><span>Novartis Group from which the Complainant is a part of is one of the biggest global pharmaceutical and healthcare groups. It provides solutions to address the evolving needs of patients worldwide by developing and delivering innovative medical treatments and drugs. The Complainant was created in 1996 through a merger of two other companies Ciba-Geigy and Sandoz, and is the holding company of the Novartis Group. In 2024, Novartis achieved net sales of USD 50.3 billion, and total net income amounted to USD 11.9 billion and employed approximately 76 000 full-time equivalent employees as of December 31, 2024.<\/span><span>&nbsp;<\/span><\/p>\n<p style=\"font-weight: 400;\"><span>The Complainant&rsquo;s products are manufactured and sold in many countries worldwide, including in the United States, where it has an active presence through associated companies and where it has been playing an active role in the local markets and societies.<\/span><\/p>\n<p style=\"font-weight: 400;\"><span>The Complainant is the owner of NOVARTIS trademarks in numerous jurisdictions around the world, including the ones cited above.<\/span><\/p>\n<p style=\"font-weight: 400;\"><span>Furthermore, the Complainant also owns domain names which include its NOVARTIS &nbsp;trademarks, such as the domain name &lt;novartis.com&gt; registered on 2 April 1996 or in combination with other terms, such as &lt;novartispharma.com&gt; registered on 27 October 1999. The Complainant uses these domain names to resolve to its official websites through which it informs Internet users and potential consumers about its NOVARTIS mark and its related products and services.<\/span><\/p>\n<p style=\"font-weight: 400;\"><span>The disputed domain name &lt;novartismanagement.com&gt; was registered on 04 March 2025 and resolves to an inactive webpage<\/span><span>. <\/span><\/p>",
    "other_legal_proceedings": "<p>The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>",
    "no_response_filed": "<div>\n<p><span lang=\"EN-GB\">The Complainant contends that the requirements of the Policy have been met and that the disputed domain name should be transferred to it.<o:p><\/o:p><\/span><\/p>\n<\/div>\n<div>\n<p><span lang=\"EN-GB\">The Complainant's contentions are the following:<o:p><\/o:p><\/span><\/p>\n<\/div>\n<div>\n<p><span lang=\"EN-GB\">The Complainant contends that the requirements of the Policy have been met and that the disputed domain name should be transferred to it.&nbsp;The disputed domain name &lt;<\/span><span lang=\"EN-GB\">novartismanagement.com<\/span><span lang=\"EN-GB\">&gt; is confusingly similar to the Complainant's earlier well-known trademark NOVARTIS, that the Respondent lacks rights or legitimate interests in the disputed domain name for a number of reasons and that the disputed domain name was registered and is being used in bad faith.<o:p><\/o:p><\/span><\/p>\n<\/div>\n<div>\n<p><span lang=\"EN-GB\">No administratively compliant Response has been filed.<o:p><\/o:p><\/span><\/p>\n<\/div>",
    "rights": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>",
    "no_rights_or_legitimate_interests": "<p>The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>",
    "bad_faith": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>",
    "procedural_factors": "<p>The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>",
    "decision": "Accepted",
    "panelists": [
        "Delia-Mihaela Belciu"
    ],
    "date_of_panel_decision": "2025-05-01 00:00:00",
    "informal_english_translation": "<p style=\"font-weight: 400;\"><span>The Complainant bases its Complaint among others on the following trademarks: <\/span><\/p>\n<ul>\n<li><span>International trademark registration &ldquo;NOVARTIS&rdquo;, no. 663765, registered on 1 July 1996, for goods and services in classes 1, 2, 3, 4, 5, 7, 8, 9, 10, 14, 16, 17, 20, 22, 28, 29, 30, 31, 32, 40, 42<\/span>;<\/li>\n<li><span>United States national trademark &ldquo;NOVARTIS&rdquo;, no. 4986124, registered on 28 June 2016, for goods and services in classes 5, 9, 10, 41, 42, 44; <\/span><\/li>\n<li><span>United States national trademark &ldquo;NOVARTIS&rdquo;, no. 6990442, registered on 28 February 2023, for goods in class 5; <\/span><\/li>\n<li><span>European Union trademark &ldquo;NOVARTIS&rdquo;, no. 000304857<\/span>, registered since 25 June 1999, for goods in classes 1, 5, 9, 10, 29, 30, 31, 32.<\/li>\n<\/ul>",
    "decision_domains": {
        "novartismanagement.com": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}